@prefix orcid: .
@prefix this: .
@prefix sub: .
@prefix np: .
@prefix rdf: .
@prefix xsd: .
@prefix rdfs: .
@prefix ns2: .
@prefix ns1: .
@prefix prov: .
@prefix ns3: .
@prefix npx: .
sub:Head {
this: np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubInfo;
a np:Nanopublication .
}
sub:assertion {
sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" .
sub:version prov:value "1"^^xsd:integer .
rdf:object ns1:C0011777 "dexamethasone";
ns1:C0178602 "doses";
ns1:C0205250 "higher" .
rdf:predicate ns2:TRIPLE_UID:1jnziuot-TRIPLE-ABSTRACT-13 "result" .
rdf:subject ns1:C0009566 "complications";
ns1:C0011777 "dexamethasone";
ns1:C0163712 "related";
ns1:C0439849 "related";
ns1:C0445223 "related";
ns1:C0802632 "complications";
ns1:C1704787 "related" .
rdfs:Triple-UID ns3:TRIPLE_UID:1jnziuot-TRIPLE-ABSTRACT-13 "1jnziuot-TRIPLE-ABSTRACT-13" .
rdfs:sentence rdfs:label "In order to increase the therapeutic efficacy of dexamethasone in COVID-19 patients, while minimizing dexamethasone-related complications that could result from using higher doses of dexamethasone, we applied a chemocentric informatics approach to identify combination therapies." .
rdfs:triple rdfs:label "dexamethasone - related complications result from using higher doses of dexamethasone" .
}
sub:provenance {
sub:assertion prov:generatedAtTime "2021-07-25T21:46:28.097567"^^xsd:dateTime .
}
sub:pubInfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB";
npx:hasSignature "fSYAamhjJuohHhse45kJNgX8J4N1wrRjXF3WiJLIuBl5Vu+MTiKKiUwho36KmhZuRzEXW1jJVlv/JJIEExMj9kDGMLiVlD3UdAwzJ/UuhW/0bIxr37k+22+7s5tTikNb/jcyNzvFehXbvnxF1joxNd82byJpuvlHCiQr468nJqI=";
npx:hasSignatureTarget this: .
this: prov:generatedAtTime "2021-07-25T21:46:28.097567"^^xsd:dateTime;
prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}